These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18435924)

  • 1. Binding of recombinant human coagulation factor VIII to lipid nanotubes.
    Parmenter CD; Stoilova-McPhie S
    FEBS Lett; 2008 May; 582(12):1657-60. PubMed ID: 18435924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes.
    Parmenter CD; Cane MC; Zhang R; Stoilova-McPhie S
    Biochem Biophys Res Commun; 2008 Feb; 366(2):288-93. PubMed ID: 18039465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.
    Dalm D; Galaz-Montoya JG; Miller JL; Grushin K; Villalobos A; Koyfman AY; Schmid MF; Stoilova-McPhie S
    Sci Rep; 2015 Jun; 5():11212. PubMed ID: 26082135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanotechnologies for structural studies of membrane-associated proteins.
    Stoilova-McPhie S; Grushin K; Dalm D; Miller J
    Proteins; 2014 Nov; 82(11):2902-9. PubMed ID: 24957666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helical organization of blood coagulation factor VIII on lipid nanotubes.
    Miller J; Dalm D; Koyfman AY; Grushin K; Stoilova-McPhie S
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24961276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII organisation on nanodiscs with different lipid composition.
    Grushin K; Miller J; Dalm D; Stoilova-McPhie S
    Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topology of factor VIII bound to phosphatidylserine-containing model membranes.
    Purohit VS; Ramani K; Kashi RS; Durrani MJ; Kreiger TJ; Balasubramanian SV
    Biochim Biophys Acta; 2003 Oct; 1617(1-2):31-8. PubMed ID: 14637017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving understanding of factor VIII binding sites and implications for the treatment of hemophilia A.
    Gilbert GE
    Blood Rev; 2019 Jan; 33():1-5. PubMed ID: 29866493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.
    Spaargaren J; Giesen PL; Janssen MP; Voorberg J; Willems GM; van Mourik JA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):539-45. PubMed ID: 7654192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy.
    Gilbert GE; Baleja JD
    Biochemistry; 1995 Mar; 34(9):3022-31. PubMed ID: 7893714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine.
    Gilbert GE; Drinkwater D
    Biochemistry; 1993 Sep; 32(37):9577-85. PubMed ID: 8373765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.
    Kotova S; Vijayasarathy C; Dimitriadis EK; Ikonomou L; Jaffe H; Sieving PA
    Biochemistry; 2010 Aug; 49(33):7023-32. PubMed ID: 20677810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain organization of membrane-bound factor VIII.
    Stoilova-McPhie S; Lynch GC; Ludtke S; Pettitt BM
    Biopolymers; 2013 Jul; 99(7):448-59. PubMed ID: 23616213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed silicon photonic sensor arrays enable facile characterization of coagulation protein binding to nanodiscs with variable lipid content.
    Muehl EM; Gajsiewicz JM; Medfisch SM; Wiersma ZSB; Morrissey JH; Bailey RC
    J Biol Chem; 2017 Sep; 292(39):16249-16256. PubMed ID: 28801460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein structure and effect of factor VIII.
    Fang H; Wang L; Wang H
    Thromb Res; 2007; 119(1):1-13. PubMed ID: 16487577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII.
    Spiegel PC; Kaiser SM; Simon JA; Stoddard BL
    Chem Biol; 2004 Oct; 11(10):1413-22. PubMed ID: 15489168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII Arg2304 --> His binds to phosphatidylserine and is a functional cofactor in the factor X-ase complex.
    Lewis DA; Moore KD; Ortel TL
    Thromb Haemost; 2001 Feb; 85(2):260-4. PubMed ID: 11246544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS.
    Pantazatos D; Gessner CR; Woods VL; Gilbert GE
    Biochem J; 2014 Aug; 461(3):443-51. PubMed ID: 24814520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.